A double-blind clinical trial of hyposensitization with aqueous extracts of Dermatophagoides pteronyssinus (the housedust mite) and human skin scales showed a substantial improvement in symptoms in 11 asthmatics allergic to house dust treated with the D.pteronyssinus extract and a reduction in their need for other therapy. Five patients were weli for a year but six relapsed. These results contrasted with the generally unfavourable course of the patients treated with the extract of human sldn scales. Asthma due to housedust allergy may be substantially improved by hyposensitization with D. pteronyssinus extract.
Introduction
The role of the house-dust mite (Dermatophagoides pteronyssinus) as the major allergen in house dust has been well established (Voorhorst et al., 1967; Maunsell et al., 1968; Morrow Brown and Filer, 1968; Pepys et al., 1968) . Patients known to be allergic to house dust also show marked skin, nasal, and bronchial allergy to the house-dust mite. The treatment of house-dust allergy by hyposensitizing injections has been disappointing (McAllen, 1961 ; British Tuberculosis Association, 1968) , presumably because of the low concentration of mite antigen in the extracts used. We therefore carried out a double-blind trial to determine the hyposensitizing effects of injections of aqueous extract of D. pteronyssinus in a small group of patients with asthma induced by house dust.
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A. P. SMITH, M.B., M.R.C.P., Lecturer Padents and Methods Twenty-two patients were selected who had perennial asthma, with or without rhinitis; attacks of asthma on contact with house dust (as in sweeping or making beds) and frequent nocturnal and early morning attacks of asthma; an immediately positive result to a prick test with 1: 10,000 extract of D. pteronyssinus; no history of other allergies; and negative skin tests to Aspergillus fumigatus, other moulds, pollens, and animal fur. Further information about them is presented in Table I . All had suffered from asthma for many years. The grading of asthma before entering the trial was based on the number of days off work in the previous six months, the severity of breathlessness, the frequency of nocturnal attacks, the frequency with which an aerosol bronchodilator was used during the month before treatment, and the type of therapy previously received by the patient.
One group of 11 patients received house-dust mite extract and the other 11 patients an extract of human skin scales. The mite extracts were prepared by Dr. Kate Maunsell in the way she has described (McAllen et al., 1970) , and the control extracts were prepared in the same fashion. There was no loss of skin-reacting property in the mite extract after heating, and the strength was unimpaired after storage at room temperature for 12 months.
The trial was divided into a run-in period of one month, an injection period, and a follow-up period of six weeks. The patients were seen weekly and assessed in the same manner each time. After the follow-up period they continued to attend but at longer intervals. Active or control treatment was dispensed to each patient at the start of the injection period in a random, double-blind fashion, and the extracts were given weekly by subcutaneous injection in doses of 0-1, 0-2, 0.4, 0-6, and 0-8 ml of 1: 100,000 extract and then 0-1, 0-2, 0-4, 0-6, 0-8, 1-0, 1-5, and 1.5 ml of 1:10,000 extract. If an immediate localized skin reaction occurred the same dose was repeated the next week.
Patients were instructed to vacuum their mattresses twice weekly and to pay particular attention to domestic hygiene. Each patient kept a daily record of symptoms, allocating scores for each symptom. The number of attacks of wheezing (day asthma score), the degree of breathlessness (points allocated on a 1-6 scale according to exercise limitation), and the number of times an aerosol inhaler was used were recorded each night. Each morning the patient recorded the night asthma score (points allocated according to the frequency of nocturnal attacks of wheeze sufficient to waken him) and the number of times the inhaler had been used during the night. At each visit to the clinic the daily scores for each symptom were summed to provide a single weekly figure for statistical purposes. The best of three consecutive peak flow rate readings and any changes of treatment were also recorded.
Results
Twenty patients completed the course of injections, and two left the trial during the injection period. They were classed as failures of treatment and were subsequently found to belong to the control group. The average course of injections lasted 16 weeks.
Ten of the 11 patients treated with mite extract completed the follow-up period without needing any further therapy, compared with 5 of the 11 patients in the control group. The difference between the number of patients in each group reaching the end of the follow-up period without additional treatment is significant (0-05>P>0 01).
At the end of the injection period the patients were asked for a subjective opinion of their treatment and the investigator recorded his own impression. Significantly more patients The results are recorded in Table III . Of the patients in the two groups significantly more in the mite-treated group were less breathless during the daytime (P<0.005), had fewer attacks of noctumal breathlessness (P<0005), and used their inhalers less at night (P<0-01).
More patients in the mite-treated group were classified as better in respect of the number of attacks of wheezing and the daytime inhaler score, but not enough to exclude the possibility of the findings being due to chance (P>0.10 and P>0 05 respectively).
The peak flow rate results showed pronounced improvement in only four mite-treated patients-a result that cannot be accorded significance (P>0-10). Rhinitis improved in four of the mite-treated patients but in none of the control group. No serious side effects were seen. Eight patients in the mitetreated group had recurrent episodes of localized wealing and erythema at the injection site. There were no intermediate or late reactions, and precipitins against D. pteronyssinus were not detected in the serum of the eight patients tested. Of 10 mite-treated patients followed up for over a year five remained well and needed no further treatment: the remainder relansed at 2, 4, 6, and 10 months respectively after the injections had ceased. It was possible to withdraw treatment from the three mite-treated patients on corticosteroid therapy but not from the four patients in the control group. The dose of disodium cromoglycate was reduced in one patient in the mite-treated group.
Discussion
Specific symptoms improved in more patients in the mitetreated group than in the control group. The improvement was associated with a favourable subjective response and reduction in other forms of treatment but was not detected by weekly measurements of air flow obstruction. It was in anticipation of the last observation that as much information as possible was sought from the patients, and clearly this decision was borne out by the results. The statistical method of evaluating the results was purposely rather insensitive, and only pronounced, persistent improvement over the whole six-week follow-up period was enough to be classified as "better." Therefore, the tendency of the measurements of airflow obstruction to vary produced occasional results during the assessment period which were low enough to exclude them from that category. Daily measurements of peak flow rate would probably have given a more reliable indication of Worse.0
If the number of patients in either group which shows improvement is significant, P <005.
Ii-significant changes. We therefore agree with Chai et al.
(1968) that as many criteria as possible need to be studied in a long-term assessment of asthmatic patients and that single, infrequent observations are of limited value. The symptoms of house-dust allergy tend to fluctuate over the course of a year (Voorhorst et al., 1967) , and the possibility that the improvement in our mite-treated group could be due to this was considered. But since no similar improvement occurred in the patients in the control group over the same period it was concluded that seasonal variation was not a significant factor. Furthermore, patients who had other seasonal allergies which could confuse the results were carefully excluded from the trial. We had no information about the mite content of the house dust in the patients' homes, but no patients moved house, installed central heating, or noticeably altered their environment in any other way during the trial. 
